MarketPulse
I

$IPSEY

3 articles found
1 positive
2 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Ipsen Unveils Early-Stage Immuno-Oncology Breakthroughs at AACR Congress

Ipsen presents preclinical data for two first-in-class cancer candidates targeting solid tumors and gastrointestinal cancers, advancing its immuno-oncology pipeline.
IPSEYantibody-drug conjugatesolid tumors
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Ipsen Withdraws Tazverik Globally While Reshuffling North America Leadership

Ipsen voluntarily withdraws Tazverik across all markets and appoints Michelle Werner as North America president, signaling strategic portfolio and leadership shifts.
IPSEYexecutive appointmentNorth America
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Ipsen Withdraws Tazverik Drug Globally, Reshuffles North America Leadership

Ipsen withdraws Tazverik globally and appoints Michelle C. Werner as North America president, signaling strategic portfolio optimization and leadership strengthening.
IPSEYexecutive appointmentNorth America